Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Maternal OCD tied to adverse pregnancy, delivery, neonatal outcomes
Pregnant women with obsessive–compulsive disorder (OCD) are at higher risk of adverse pregnancy, delivery, and neonatal outcomes, including gestational diabetes, pre-eclampsia, caesarean delivery, preterm birth, neonatal respiratory distress, neonatal infections, and major congenital malformations, among others, as reported in a study.
Maternal OCD tied to adverse pregnancy, delivery, neonatal outcomes
19 Jun 2023Cumulative immunomodulator exposure may heighten risk of CIN2+ in IBD
Among women with inflammatory bowel disease (IBD), those who have long-term immunomodulator exposure are at increased risk of high-grade cervical intraepithelial neoplasia and cervical cancer (CIN2+), according to a study.
Cumulative immunomodulator exposure may heighten risk of CIN2+ in IBD
16 Jun 2023Ribociclib plus endocrine therapy: A win for early breast cancer?
In the second interim efficacy analysis of the phase III NATALEE trial, a combination regimen comprising the CDK4/6 inhibitor ribociclib and endocrine therapy (ET) demonstrated favourable signals for the adjuvant treatment of stage II/III hormone receptor-positive, HER2-negative (HR+, HER2–) early breast cancer.
Ribociclib plus endocrine therapy: A win for early breast cancer?
16 Jun 2023Add-on myoinositol helps with menstrual period regularity in women with PCOS
In the treatment of women with polycystic ovary syndrome (PCOS), adding myoinositol to metformin provides further benefits for improving the regularity of menstrual cycle, with subsequent gains in quality of life, according to a study.
Add-on myoinositol helps with menstrual period regularity in women with PCOS
12 Jun 2023Pazopanib plus chemo improves response but not survival in advanced ovarian cancer
Treatment with pazopanib combined with chemotherapy leads to better overall response rate (ORR) in patients with recurrent or persistent ovarian cancer but falls short of improving survival, reveals a study. In addition, the combination therapy contributes to an increase in several adverse events (AEs).